The future cost of producing cancer drugs may have dropped in price with the laying of eggs from genetically-modified chickens.Roslin Institute scientists have announced the successful creation of five generations of chickens that can lay eggs containing a specific protein needed to manufacture drugs used in the treatment of cancer. The Roslin Institute is the same research facility that cloned the Finn Dorset lamb named Dolly.
According to the BBC News report that states, "the work at Roslin shows it is now possible to use chickens as biofactories," more than one genetically-modified animal is being used as just such a factory for complex proteins needed to produce drugs.
It will be five-to-ten years before the drugs made from the protein of eggs from these genetically-modified chickens can be safely used, if clinical trials show favorable outcomes.


Remember Dolly the first successfully cloned sheep? In 1997, a scientist named Ian Wilmut stunned the world when he announced he had successfully cloned a sheep from an adult cell. With a new book,
In 2003, University of Idaho and Utah State University researchers cloned three mules. The success of the cloning
came about by manipulating calcium levels. Calcium affects how quickly cells divide. The researchers are hoping that
calcium levels and function might explain why horses and mules develop cancer at much lower rates than humans. Because
of these cloning facts and findings, they base a possible hypothesis for discovering a key to cancer on the fact that
calcium imbalances are indicators of human 







